These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25188231)

  • 21. Pediatric nephrolithiasis and the link to bone metabolism.
    Schwaderer AL; Kusumi K; Ayoob RM
    Curr Opin Pediatr; 2014 Apr; 26(2):207-14. PubMed ID: 24535494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoporosis and urolithiasis.
    Caudarella R; Vescini F; Buffa A; La Manna G; Stefoni S
    Urol Int; 2004; 72 Suppl 1():17-9. PubMed ID: 15133327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced vertebral bone density in hypercalciuric nephrolithiasis.
    Pietschmann F; Breslau NA; Pak CY
    J Bone Miner Res; 1992 Dec; 7(12):1383-8. PubMed ID: 1481724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT-Based Diagnosis of Low Vertebral Bone Mineral Density Is Associated with Hypercalciuria and Hypocitraturia on Opportunistic Imaging.
    Patel ND; Ward RD; Calle J; Remer EM; Monga M
    J Endourol; 2018 Sep; 32(9):878-883. PubMed ID: 29954225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-centered medical therapy for nephrolithiasis.
    Marchini GS; Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Monga M
    Urology; 2013 Mar; 81(3):511-6. PubMed ID: 23452804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypercalciuria].
    Wróblewski T; Wystrychowski A
    Przegl Lek; 2011; 68(2):107-13. PubMed ID: 21751520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
    Abu-Ghanem Y; Kleinmann N; Erlich T; Winkler HZ; Zilberman DE
    Isr Med Assoc J; 2021 Jan; 23(1):12-16. PubMed ID: 33443336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.
    Pacifici R; Rothstein M; Rifas L; Lau KH; Baylink DJ; Avioli LV; Hruska K
    J Clin Endocrinol Metab; 1990 Jul; 71(1):138-45. PubMed ID: 2370292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal stone disease: Causes, evaluation and medical treatment.
    Heilberg IP; Schor N
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):823-31. PubMed ID: 17117307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal calcium conservation in recurrent stone-formers with idiopathic hypercalciuria.
    Goulding A; Hocken AG
    N Z Med J; 1985 Feb; 98(772):50-2. PubMed ID: 2983270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal calcium excretion and urolithiasis].
    Aruga S; Honma Y
    Clin Calcium; 2011 Oct; 21(10):1465-72. PubMed ID: 21960231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of hypercalciuria in patients with osteopenia versus osteoporosis.
    Girón-Prieto MS; Del Carmen Cano-García M; Poyatos-Andújar A; Arias-Santiago S; de Haro-Muñoz T; Arrabal-Martín M; Arrabal-Polo MÁ
    Urolithiasis; 2017 Jun; 45(3):279-283. PubMed ID: 27480097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium-phosphate cotransporters, nephrolithiasis and bone demineralization.
    Prié D; Beck L; Friedlander G; Silve C
    Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):675-81. PubMed ID: 15483460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria.
    Skalova S; Palicka V; Kutilek S
    Nephrology (Carlton); 2005 Apr; 10(2):99-102. PubMed ID: 15877664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone disease in medullary sponge kidney and effect of potassium citrate treatment.
    Fabris A; Bernich P; Abaterusso C; Marchionna N; Canciani C; Nouvenne A; Zamboni M; Lupo A; Gambaro G
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1974-9. PubMed ID: 19808216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.